Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:42 PM UTC
| NCT Number | NCT06627647 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,160 participants |
| Active Locations | 78 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 23, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT06627647 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 78 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06627647 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 78 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06627647 was last updated 3 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.